Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer

Condition:   Head and Neck Neoplasms
Interventions:   Drug: NC-6004;   Drug: Cetuximab;   Drug: 5-FU
Sponsors:   Orient Europharma Co., Ltd.;   Nanocarrier Co., Ltd.
Recruiting - verified June 2016

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/29971wn
via IFTTT